TECTONIC THERAPEUTIC, INC. Other Nonoperating Expense
TECTONIC THERAPEUTIC, INC. (TECX) reported Other Nonoperating Expense of $78.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-14.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2024-03-14
- TECTONIC THERAPEUTIC, INC. other nonoperating expense for the quarter ending 2022-03-31 was $45.00K, a 80.00% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. other nonoperating expense for the quarter ending 2021-06-30 was $21.00K, a 36.36% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. other nonoperating expense for the quarter ending 2021-03-31 was $25.00K, a 56.25% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. other nonoperating expense for the quarter ending 2020-12-31 was $80.00K, a 370.59% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. other nonoperating expense for fiscal 2023 was $78.00K, a 50.32% decline from fiscal 2022.
- TECTONIC THERAPEUTIC, INC. other nonoperating expense for fiscal 2022 was $157.00K, a 157.38% increase from fiscal 2021.
- TECTONIC THERAPEUTIC, INC. other nonoperating expense for fiscal 2021 was $61.00K, a 69.95% decline from fiscal 2020.
- TECTONIC THERAPEUTIC, INC. other nonoperating expense for fiscal 2020 was $203.00K, a 125.56% increase from fiscal 2019.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month | Other Nonoperating Expense 9 month | Other Nonoperating Expense 12 month |
|---|---|---|---|---|
| 2023-12-31 | $78.00K 10-K · filed 2024-03-14 | |||
| 2022-12-31 | $157.00K 10-K · filed 2024-03-14 | |||
| 2022-03-31 | $45.00K 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | $61.00K 10-K · filed 2023-03-23 | |||
| 2021-06-30 | $21.00K 10-Q · filed 2021-08-05 | $46.00K 10-Q · filed 2021-08-05 | $126.00K derived: sum of 3 quarters · filed 2022-05-10 | $200.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-03-31 | $25.00K 10-Q · filed 2022-05-10 | $105.00K derived: sum of 2 quarters · filed 2022-05-10 | $179.00K derived: sum of 3 quarters · filed 2022-05-10 | $212.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $154.00K derived: sum of 2 quarters · filed 2022-03-17 | $187.00K derived: sum of 3 quarters · filed 2022-03-17 | $203.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | $74.00K 10-Q · filed 2020-11-05 | $107.00K derived: sum of 2 quarters · filed 2021-08-05 | $123.00K 10-Q · filed 2020-11-05 | $140.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-06-30 | $33.00K 10-Q · filed 2021-08-05 | $49.00K 10-Q · filed 2021-08-05 | $66.00K derived: sum of 3 quarters · filed 2021-08-05 | $72.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $16.00K 10-Q · filed 2021-05-13 | $33.00K derived: sum of 2 quarters · filed 2021-05-13 | $39.00K derived: sum of 3 quarters · filed 2021-05-13 | $47.00K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $23.00K derived: sum of 2 quarters · filed 2021-03-18 | $31.00K derived: sum of 3 quarters · filed 2021-03-18 | $90.00K 10-K · filed 2021-03-18 |
| 2019-09-30 | $6.00K 10-Q · filed 2020-11-05 | $14.00K derived: sum of 2 quarters · filed 2020-11-05 | $73.00K 10-Q · filed 2020-11-05 | $107.00K derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $8.00K 10-Q · filed 2020-08-06 | $68.00K 10-Q · filed 2020-08-06 | $101.00K derived: sum of 3 quarters · filed 2020-08-06 | $106.00K derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $60.00K 10-Q · filed 2020-05-07 | $93.00K derived: sum of 2 quarters · filed 2020-05-07 | $98.00K derived: sum of 3 quarters · filed 2020-05-07 | $100.00K derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $38.00K derived: sum of 2 quarters · filed 2020-03-16 | $40.00K derived: sum of 3 quarters · filed 2020-03-16 | $53.00K 10-K · filed 2020-03-16 |
| 2018-09-30 | $5.00K 10-Q · filed 2019-11-07 | $7.00K derived: sum of 2 quarters · filed 2019-08-08 | $20.00K 10-Q · filed 2019-11-07 | $20.00K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-06-30 | $2.00K 10-Q · filed 2019-08-08 | $15.00K 10-Q · filed 2019-08-08 | $15.00K derived: sum of 3 quarters · filed 2019-08-08 | $29.00K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $13.00K 10-Q · filed 2019-05-13 | $13.00K derived: sum of 2 quarters · filed 2019-05-13 | $27.00K derived: sum of 3 quarters · filed 2019-05-13 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $14.00K derived: sum of 2 quarters · filed 2019-03-25 | $19.00K 10-K · filed 2019-03-25 | |
| 2017-09-30 | $14.00K 10-Q · filed 2018-11-13 | $19.00K 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | $5.00K 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |